Linda S. Andrews, MSN, RN, CCRC, CCRP


Linda Andrews leads the Clinical Engagement Team, which provides education, training, and ongoing support on Inteliquet’s platform for clinicians, nurses, CROs, clinical trial design teams, and research staff. With 30+ years of nursing, clinical research, training, and leadership experience, Linda is an expert in best-practice techniques and strategies that accelerate clinical trial enrollment.

Before Inteliquet, Linda worked at Novartis Pharmaceuticals as a Regional Manager for their Patient and Specialty Services Division, managing nurse educators. Her responsibilities included streamlining on-boarding, building relationships with National Key Opinion Leaders, providing patient education and clinical resource support for physicians and office staff, and acting as the program liaison for sales, marketing, and managed care. In her first year, she decreased the first-start day from 104 days to 22 days, a 79% efficiency improvement. Two years later she, decreased the national first-start days from 122 to 17 days, an 84% improvement. Linda was also a key player in increasing the first-time managed market approvals from 15% to 95%.

Prior to Novartis, Linda was Director of Clinical Studies at VASCUTEK, a subsidiary of Terumo Corporation, and manufacturer of vascular and cardiovascular products. In addition to managing U.S. and Canadian clinical trials with budgets exceeding $5M, she was a medical and scientific resource for feasibility studies, leading clinical operations and project management for 510k and Class III IDE medical device studies. She oversaw research associates and field medical device clinical specialists, and supported education and training of all internal/external customers of the clinical trial process. Her work also involved managing FDA reporting requirements, including endpoint and pre-IDE submissions.

Prior to VASCUTEK, Linda was Clinical Research Manager/Lead Coordinator and Nurse Educator at the Jobst Vascular Institute, part of the ProMedica Health System in Toledo, Ohio. She managed clinical research staff for trials of bleeding disorders, cardiovascular, endovascular, peripheral vascular disease, and wound care ranging from medical device class III and pharmaceutical phase I-IV trials. She also was responsible for financial and budgetary reporting for $1-5M studies as well as regulatory management, investigational study site selection, and site/sponsor relationships.

Linda also was an Investigation Review Board (IRB) reviewer and a ProMedica Health board member. Earlier, she worked in the Adult Medicine and Specialty Clinic as an Ambulatory Clinic Nurse and Educator, where she developed, implemented, and tracked department and patient educational materials. She educated staff on a range of subjects from orientation and equipment updates to JCAHO and HIPAA training. She also handled patient Inclusion/Exclusion for selected cardiovascular and oncology research programs and conducted patient education for diabetic and hepatitis C injection training. Linda began her career at the Toledo Hospital, where she spent 18 years in RN roles in cardiovascular recovery and stress testing, coronary intensive care, cardiac rehabilitation, neurology intensive care, and inpatient pain management.

Linda holds a master’s degree (summa cum laude) in the Science of Nursing from Walden University in Minneapolis, Minn. She also has a bachelor’s degree (summa cum laude) in Education and an associate degree in Nursing both from the University of Toledo. She holds three certifications in clinical research and has been published in the Journal of Vascular Nursing, Journal of Vascular Surgery, and Journal of Internal Medicine.

“I’ve wanted to be a nurse since I was five years old, when I told my grandmother I would grow up and take care of her. Years later, I helped care for her during her last days at home, when she went into Hospice care. Cancer has affected many in my family and close friends, both young and old. It is urgent that everyone have access to clinical trials when facing a cancer diagnosis or another debilitating disease. I work daily to help healthcare providers and their staffs find alternative treatment options when the time-to-treatment counts.”


© Copyright 2021 Inteliquet, Inc. All rights reserved.